The treatment of End-stage Renal Disease (ESRD), through dialysis, involves removal of toxins and excess fluids from the bloodstream, by artificial means.
TechNavio has announced this week the launch of the report Dialysis Products Market in the US 2008-2012.
According to TechNavio Insights, the market for Dialysis products in the US is expected to reach $6,766.4 million by 2012, from $5,086.4 million in 2008; thus, growing at a CAGR of 7.4 percent over the forecast period.
The United States Renal Data System (USRDS) estimates that there is a high prevalence of renal failure cases, especially in the economically developed countries. The main cause for this can be attributed to the dietary habits of the people.
In the US, the number of people willing to donate their kidneys for transplantation to the ESRD patients is very less. The Dialysis products market in the US is witnessing an increase in the number of patients suffering from chronic kidney failure. The increasing cases of hypertension, diabetes, and cardiovascular diseases among the kidney patients are the major reasons for deaths among the patients, says a TechNavio expert.
The report showcases the various aspects of the Dialysis products in the US. It forecasts the market size of the products used for dialysis in the US over the period 2008-2012, and provides segmentation of the Dialysis products in the US market.
For further information about the major market trends, drivers, and challenges existing for the Dialysis products in the US please visit https://www.technavio.com/content/dialysis-products-market-united-states-….
Dialysis Products Market in the US 2008-2012
